• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee

    5/3/22 9:15:00 AM ET
    $COSM
    $ESEA
    Other Pharmaceuticals
    Health Care
    Marine Transportation
    Consumer Discretionary
    Get the next $COSM alert in real time by email

    CHICAGO, IL / ACCESSWIRE / May 3, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced it has appointed finance veteran Dr. Anastasios Aslidis to the Board of Directors and as a member of the Board's audit committee.

    Dr. Anastasios Aslidis currently serves as the Chief Financial Officer and Treasurer, as well as a member of the Board of Directors of EuroDry (EDRY) since 2018. He is Chief Financial Officer, Treasurer and a member of the Board of Directors of Euroseas (NASDAQ:ESEA) since September 2005. Furthermore, Dr. Aslidis has been a director of Vianair Inc., a private company active in airspace design and airport operations analysis since 2017. Prior to joining Euroseas, Dr. Aslidis was a partner at Marsoft Inc., an international consulting firm focusing on investment and risk management in the maritime industry. Dr. Aslidis has more than 30 years of experience in the maritime industry. He also served as consultant to the Boards of Directors of public and private companies advising on strategy development, asset selection and investment timing. Dr. Aslidis holds a Ph.D. in Ocean Systems Management (1989) from the Massachusetts Institute of Technology, M.S. in Operations Research (1987) and M.S. in Ocean Systems Management (1984), also from the Massachusetts Institute of Technology, and a Diploma in Naval Architecture and Marine Engineering from the National Technical University of Athens (1983).

    Greg Siokas, Chief Executive Officer of Cosmos Holdings, stated, "We are pleased to welcome Dr. Aslidis to the board and to the audit committee. Dr. Aslidis brings an impressive track record and decades of experience in corporate finance and capital markets. His operational and financial experience will play an important role as we continue to scale our business and expand our footprint worldwide."

    "Over the past years, I have watched Cosmos aggressively grow its product line and expand its distribution network," said Dr. Aslidis. "I am excited to join the Board now to help contribute to its next phase of growth as Cosmos takes the necessary steps to become a leading global nutraceutical and pharmaceutical distribution company."

    About Cosmos Holdings, Inc.

    Cosmos Holdings Inc. (NASDAQ:COSM) is an international pharmaceutical company, with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices through an extensive, established EU distribution network. The Company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.

    Forward-Looking Statements

    With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    Investor Relations Contact:
    Crescendo Communications, LLC
    Tel: 212-671-1020
    Email: [email protected]

    SOURCE: Cosmos Holdings, Inc.



    View source version on accesswire.com:
    https://www.accesswire.com/699910/Cosmos-Holdings-Appoints-Finance-Veteran-Dr-Anastasios-Aslidis-to-the-Board-of-Directors-and-as-a-Member-of-the-Boards-Audit-Committee

    Get the next $COSM alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $COSM
    $ESEA

    CompanyDatePrice TargetRatingAnalyst
    Euroseas Ltd.
    $ESEA
    9/9/2024$60.00Buy
    Alliance Global Partners
    Euroseas Ltd.
    $ESEA
    12/31/2021$48.00 → $50.00Buy
    Maxim Group
    Euroseas Ltd.
    $ESEA
    6/25/2021$28.00 → $38.00Buy
    Maxim Group
    More analyst ratings

    $COSM
    $ESEA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Euroseas Ltd. Announces Annual Meeting of Shareholders

      ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ:ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that its Board of Directors has called an annual meeting of the shareholders to be held on July 23, 2025, at 11:00 a.m. at the offices of Seward & Kissel LLP, located at 901 K Street NW, Suite 800, Washington, DC 20001. Shareholders of record at the close of business on June 25, 2025, are entitled to receive notice of, and to vote at, the Annual Meeting, or any adjournments or postponements thereof. The Company's Proxy Statement, annual report on Form 20-F, which contains the Com

      7/2/25 4:10:00 PM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • Euroholdings Ltd Reports Results for the Quarter Ended March 31, 2025 and Declares First Quarterly Common Stock Dividend Following Spin - Off

      ATHENS, Greece, June 25, 2025 (GLOBE NEWSWIRE) -- Euroholdings Ltd (NASDAQ:EHLD, the "Company" or "Euroholdings")), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the quarter ended March 31, 2025. The Company was incorporated by Euroseas Ltd. (NASDAQ:ESEA, or ", Euroseas", )) to serve as the holding company of three subsidiaries that were contributed by Euroseas to Euroholdings effective January 1, 2025; Euroseas spun-off Euroholdings on March 17, 2025, which has since operated as an independent company. The results below refer to Euroholdings and its subsidiaries for the periods presente

      6/25/25 4:05:00 PM ET
      $EHLD
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

      CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic agreement with DolCas Biotech LLC ("DolCas"), a New Jersey-based developer and manufacturer of clinically studied nutraceutical ingredients. Cosmos Health is set to commence production in the United States at GMP-certified (Good Man

      6/24/25 10:55:32 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care

    $COSM
    $ESEA
    SEC Filings

    See more
    • SEC Form 6-K filed by Euroseas Ltd.

      6-K - EUROSEAS LTD. (0001341170) (Filer)

      7/2/25 5:25:52 PM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • SEC Form 6-K filed by Euroseas Ltd.

      6-K - EUROSEAS LTD. (0001341170) (Filer)

      6/20/25 4:56:01 PM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • SEC Form 6-K filed by Euroseas Ltd.

      6-K - EUROSEAS LTD. (0001341170) (Filer)

      6/4/25 8:14:45 AM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary

    $COSM
    $ESEA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Siokas Grigorios bought $15,217 worth of shares (34,004 units at $0.45), increasing direct ownership by 0.56% to 6,158,884 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/27/25 9:33:43 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Siokas Grigorios bought $62,800 worth of shares (141,825 units at $0.44), increasing direct ownership by 2% to 6,124,880 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/23/25 12:18:06 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Siokas Grigorios bought $82,000 worth of shares (174,172 units at $0.47), increasing direct ownership by 3% to 5,983,055 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/22/25 10:33:17 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care

    $COSM
    $ESEA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cosmos Health Inc.

      SC 13G/A - Cosmos Health Inc. (0001474167) (Subject)

      11/14/24 4:50:24 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Cosmos Health Inc.

      SC 13G - Cosmos Health Inc. (0001474167) (Subject)

      2/14/24 3:33:29 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13D/A filed by Cosmos Health Inc. (Amendment)

      SC 13D/A - Cosmos Health Inc. (0001474167) (Subject)

      7/25/23 4:06:11 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care

    $COSM
    $ESEA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Siokas Grigorios bought $15,217 worth of shares (34,004 units at $0.45), increasing direct ownership by 0.56% to 6,158,884 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/27/25 9:33:43 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Siokas Grigorios bought $62,800 worth of shares (141,825 units at $0.44), increasing direct ownership by 2% to 6,124,880 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/23/25 12:18:06 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Siokas Grigorios bought $82,000 worth of shares (174,172 units at $0.47), increasing direct ownership by 3% to 5,983,055 units (SEC Form 4)

      4 - Cosmos Health Inc. (0001474167) (Issuer)

      5/22/25 10:33:17 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care

    $COSM
    $ESEA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Euroseas with a new price target

      Alliance Global Partners initiated coverage of Euroseas with a rating of Buy and set a new price target of $60.00

      9/9/24 7:31:04 AM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • Maxim Group reiterated coverage on Euroseas with a new price target

      Maxim Group reiterated coverage of Euroseas with a rating of Buy and set a new price target of $50.00 from $48.00 previously

      12/31/21 9:37:17 AM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • Maxim Group reiterated coverage on Euroseas with a new price target

      Maxim Group reiterated coverage of Euroseas with a rating of Buy and set a new price target of $38.00 from $28.00 previously

      6/25/21 7:54:06 AM ET
      $ESEA
      Marine Transportation
      Consumer Discretionary

    $COSM
    $ESEA
    Financials

    Live finance-specific insights

    See more
    • Euroholdings Ltd Reports Results for the Quarter Ended March 31, 2025 and Declares First Quarterly Common Stock Dividend Following Spin - Off

      ATHENS, Greece, June 25, 2025 (GLOBE NEWSWIRE) -- Euroholdings Ltd (NASDAQ:EHLD, the "Company" or "Euroholdings")), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the quarter ended March 31, 2025. The Company was incorporated by Euroseas Ltd. (NASDAQ:ESEA, or ", Euroseas", )) to serve as the holding company of three subsidiaries that were contributed by Euroseas to Euroholdings effective January 1, 2025; Euroseas spun-off Euroholdings on March 17, 2025, which has since operated as an independent company. The results below refer to Euroholdings and its subsidiaries for the periods presente

      6/25/25 4:05:00 PM ET
      $EHLD
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • EuroHoldings Ltd. Sets Date for the Release of First Quarter 2025 Results

      ATHENS, Greece, June 24, 2025 (GLOBE NEWSWIRE) -- EuroHoldings Ltd. (NASDAQ:EHLD) ("EuroHoldings" or the "Company") an owner and operator of ocean-going vessels and provider of seaborne transportation, announced today that, that it will release its financial results for the first quarter ended March 31, 2025, on Wednesday, June 25, 2025, after market closes in New York. The Company will not host a conference call to discuss its results for the three-month period at this time. For any inquiries, stakeholders may contact the Company's Investor Relations using the information listed below. About EuroHoldings Ltd. EuroHoldings Ltd. was incorporated on March 20, 2024, under the laws of the R

      6/24/25 9:00:00 AM ET
      $EHLD
      $ESEA
      Marine Transportation
      Consumer Discretionary
    • Euroseas Ltd. Reports Results for the Quarter Ended March 31, 2025 and Declares Quarterly Common Stock Dividend

      ATHENS, Greece, June 18, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ:ESEA, the "Company" or "Euroseas")), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the three-month period ended March 31, 2025 and declared a common stock dividend. First Quarter 2025 Financial Highlights: Total net revenues of $56.3 million. Net income of $36.9 million or $5.31 and $5.29 earnings per share basic and diluted, respectively. Adjusted net income1 for the period was $26.2 million or $3.76 per share basic and diluted. Adjusted EBITDA1 was $37.1 million. An average of 23.71 vessels were owned and opera

      6/18/25 8:00:48 AM ET
      $EHLD
      $ESEA
      Marine Transportation
      Consumer Discretionary

    $COSM
    $ESEA
    Leadership Updates

    Live Leadership Updates

    See more
    • Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

      CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the full year ended December 31, 2024. Full Year 2024 Financial Highlights Income Statement: FY 2024 performance was marked by revenue growth, an increase in R&D investments, and a substantial reduction in operating expenses, while bottom-line results were impacted by the absence of non-recurring gain

      4/16/25 12:45:15 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

      CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology at the Company's Research and Development division.Professor Trafalis currently serves as a Professor of Pharmacology and Clinical Pharmacology at the Faculty of Medicine, National and Kapodistrian University of Athens.He is a medical specialist in onc

      12/26/24 1:30:00 PM ET
      $COSM
      Other Pharmaceuticals
      Health Care
    • Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share

      THESSALONIKI, GREECE / ACCESSWIRE / November 21, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today provided a business update and reported financial results for the third quarter and nine months ended September 30, 2023.Third Quarter 2023 Financial HighlightsRevenues increased to $12.8 million from $12.0 million in Q3 2022, largely due to increased sales attributable to the logistics distribution business, which expanded

      11/21/23 9:00:00 AM ET
      $COSM
      Other Pharmaceuticals
      Health Care